Cubist Systematic Strategies’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Cubist Systematic Strategies’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,761	Closed	-$16K	–	4827
2022 Q3	$16K	Hold	2,761	–	–	﹤0.01%	4258
2022 Q2	$12K	Hold	2,761	–	–	﹤0.01%	4259
2022 Q1	$32K	Hold	2,761	–	–	﹤0.01%	3439
2021 Q4	$50K	Sell	2,761 -8,476	-75%	-$108K	﹤0.01%	3313
2021 Q3	$133K	Buy	+11,237	New	+$164K	﹤0.01%	2687

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Cubist Systematic Strategies's OYST Position: Q4 2022 in Review

Cubist Systematic Strategies sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q4 2022, closing a stake of 2,761 shares — an estimated $16K sold.

Cubist Systematic Strategies first reported a position in OYST in Q3 2021 and held it in 5 quarters. The position peaked at $133K in Q3 2021. 53 funds tracked by Wall St. Rank hold OYST as of Q4 2022.

Cubist Systematic Strategies reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Cubist Systematic Strategies sold 2,761 Oyster Point Pharma, Inc. Common Stock shares in Q4 2022, an estimated $16K.
Cubist Systematic Strategies first reported a position in Oyster Point Pharma, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
Cubist Systematic Strategies's Oyster Point Pharma, Inc. Common Stock position peaked at $133K in Q3 2021.
53 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q4 2022.

Based on Cubist Systematic Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.